Jai L Shah1,2,3,4, Neeraj Tandon1,5, Debra M Montrose6, Diana Mermon6, Shaun M Eack7, Jean Miewald6, Matcheri S Keshavan1,2,6. 1. Massachusetts Mental Health Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 2. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 3. PEPP-Montréal, Douglas Mental Health University Institute, Montréal, Canada. 4. Department of Psychiatry, McGill University, Montréal, Canada. 5. Baylor College of Medicine, Houston, Texas. 6. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 7. University of Pittsburgh School of Social Work, Pittsburgh, Pennsylvania.
Abstract
AIM: While the course of psychopathology has been explored from an index mental health diagnosis onwards, there are few detailed, prospective studies of the occurrence of clinical psychopathology in youth with familial risk for severe mental illnesses such as psychosis. We sought to describe the appearance of Axis I psychopathology in a unique sample of adolescents with a family history of schizophrenia (FHR). METHODS: One hundred and sixty two first- and second-degree relatives (mean age 15.7 ± 3.6; range 8-25) of probands with schizophrenia or schizoaffective disorder were assessed at baseline and annual intervals for up to 3 years, focusing on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) Axis I psychopathology. RESULTS: Fourteen individuals (8.6%) developed a psychotic disorder. One hundred and five subjects (65%) met criteria for an Axis I disorder over the course of the study, the most common of which was a depressive episode (40 subjects; 25%). Of the 148 individuals who did not develop psychosis, 91 (61%) had one or more Axis I disorders compared with 10/14 converters who had a comorbid Axis I disorder (71%). Ordered by increasing age of onset, diagnoses included cognitive and externalizing disorders, anxiety disorders, affective disorders, substance use disorders and psychotic disorders. CONCLUSIONS: In addition to an elevated risk of psychosis, young FHR relatives manifest a broad range of non-psychotic Axis I psychopathology in childhood and adolescence. This breadth of diagnoses has implications for the structure and function of mental health services for young people.
AIM: While the course of psychopathology has been explored from an index mental health diagnosis onwards, there are few detailed, prospective studies of the occurrence of clinical psychopathology in youth with familial risk for severe mental illnesses such as psychosis. We sought to describe the appearance of Axis I psychopathology in a unique sample of adolescents with a family history of schizophrenia (FHR). METHODS: One hundred and sixty two first- and second-degree relatives (mean age 15.7 ± 3.6; range 8-25) of probands with schizophrenia or schizoaffective disorder were assessed at baseline and annual intervals for up to 3 years, focusing on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) Axis I psychopathology. RESULTS: Fourteen individuals (8.6%) developed a psychotic disorder. One hundred and five subjects (65%) met criteria for an Axis I disorder over the course of the study, the most common of which was a depressive episode (40 subjects; 25%). Of the 148 individuals who did not develop psychosis, 91 (61%) had one or more Axis I disorders compared with 10/14 converters who had a comorbid Axis I disorder (71%). Ordered by increasing age of onset, diagnoses included cognitive and externalizing disorders, anxiety disorders, affective disorders, substance use disorders and psychotic disorders. CONCLUSIONS: In addition to an elevated risk of psychosis, young FHR relatives manifest a broad range of non-psychotic Axis I psychopathology in childhood and adolescence. This breadth of diagnoses has implications for the structure and function of mental health services for young people.
Authors: Jean Addington; Barbara A Cornblatt; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen Journal: Am J Psychiatry Date: 2011-04-15 Impact factor: 18.112
Authors: Andor E Simon; Eva Velthorst; Dorien H Nieman; Don Linszen; Daniel Umbricht; Lieuwe de Haan Journal: Schizophr Res Date: 2011-07-23 Impact factor: 4.939
Authors: Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun M Eack; Alan N Francis; Jean M Miewald; Debra M Montrose; Matcheri S Keshavan Journal: Neuroimage Date: 2010-05-02 Impact factor: 6.556
Authors: Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun Eack; Rajaprabhakaran Rajarethinam; Alan N Francis; Debra M Montrose; Matcheri S Keshavan Journal: J Psychiatr Res Date: 2010-06-11 Impact factor: 4.791
Authors: Tejas S Bhojraj; Vaibhav A Diwadkar; John A Sweeney; Konasale M Prasad; Shaun M Eack; Debra M Montrose; Matcheri S Keshavan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-01-29 Impact factor: 5.067
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Eve C Johnstone; Klaus P Ebmeier; Patrick Miller; David G C Owens; Stephen M Lawrie Journal: Br J Psychiatry Date: 2005-01 Impact factor: 9.319
Authors: M Heslin; B Lomas; J M Lappin; K Donoghue; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; P Dazzan; C Morgan; G A Doody Journal: Psychol Med Date: 2015-05-04 Impact factor: 7.723
Authors: Jerome H Taylor; Nana Asabere; Monica E Calkins; Tyler M Moore; Sunny X Tang; Rose Mary Xavier; Alison K Merikangas; Daniel H Wolf; Laura Almasy; Ruben C Gur; Raquel E Gur Journal: Schizophr Res Date: 2019-12-26 Impact factor: 4.939
Authors: Laila Hasmi; Lotta-Katrin Pries; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Gunter Kenis; Alexander Richards; Bochao D Lin; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz; Jim van Os Journal: Epidemiol Psychiatr Sci Date: 2021-07-06 Impact factor: 6.892